脑卒中损伤后神经再生和功能恢复: 神经干细胞治疗正朝着临床应用迈进

Y Jiao, YW Liu, WG Chen, J Liu - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
Stroke is a main cause of death and disability worldwide. The ability of the brain to self-
repair in the acute and chronic phases after stroke is minimal; however, promising stem cell …

[HTML][HTML] Neuroregeneration and functional recovery after stroke: advancing neural stem cell therapy toward clinical application

Y Jiao, YW Liu, WG Chen, J Liu - Neural regeneration research, 2021 - journals.lww.com
Stroke is a main cause of death and disability worldwide. The ability of the brain to self-
repair in the acute and chronic phases after stroke is minimal; however, promising stem cell …

缺血性脑卒中神经修复和再生的新策略: 神经干细胞疗法

S Wang, Q He, Y Qu, W Yin, R Zhao, X Wang… - 中国神经再生研究 …, 2024 - sjzsyj.com.cn
缺血性脑卒中是导致全球死亡和残疾的主要原因, 而临床上可供选择的治疗方法却很有限.
干细胞疗法的出现为恢复脑神经元功能的脑卒中治疗领域带来了新希望. 外源性神经干细胞 …

Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy

S Wang, Q He, Y Qu, W Yin, R Zhao, X Wang… - Neural Regeneration … - journals.lww.com
Ischemic stroke is a major cause of mortality and disability worldwide, with limited treatment
options available in clinical practice. The emergence of stem cell therapy has provided new …

Research advances in endogenous neural stem cells promoting neural repair after ischemic stroke

CY Fang, XS Wu, H Zhang, YL Gu… - Sheng li xue bao …, 2019 - europepmc.org
Neural stem cell therapy, as a new therapeutic method for neural diseases, has aroused a
wide concern for over 20 years since neural stem cells were first found in 1992. Ischemic …

Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function

EW Baker, HA Kinder, FD West - Brain and behavior, 2019 - Wiley Online Library
Abstract Introduction Neural stem cells (NSCs) have demonstrated multimodal therapeutic
function for stroke, which is the leading cause of long‐term disability and the second leading …

内源性神经干细胞促进缺血性脑卒中后神经修复的研究进展

房昌运, 吴旭升, 张航, 谷燕苓, 王士兵, 任慧文, 陈珂… - 生理学报, 2019 - cqvip.com
神经干细胞自1992 年被发现以来, 已成为治疗神经系统各类疾病的新希望. 缺血性脑卒中因其高
发病率, 高致死率和高致残率而倍受关注. 损伤后的大脑自我修复能力有限 …

神经干细胞治疗缺血性脑损伤研究进展

张波, 王任直 - 中华神经外科疾病研究杂志, 2004 - cqvip.com
缺血性脑血管病是严重威胁人类健康的常见病和多发病, 其病理过程涉及复杂的时间和空间级联
反应, 虽然对其机制的了解越来越深入, 但有效的治疗手段仍然缺乏. 对于大多数脑缺血患者 …

内源性神经干细胞在缺血性脑卒中后损伤修复的动员策略及机制研究进展

张四美, 金亚菊, 杨晰宸, 张彭跃, 寸勇丹 - 神经损伤功能重建, 2022 - sjssygncj.chmed.net
脑卒中具有高发病率, 高死亡率, 高致残的特点, 是导致我国成年人死亡和残疾的首要原因.
卒中的病理机制尚未完全明确, 目前仍缺乏有效的临床治疗措施. 内源性神经干细胞(eNSCs) …

对比不同类型干细胞对于缺血性脑卒中治疗的研究进展

王铎, 林琳, 岳辉, 王毅飞, 付锦 - 现代生物医学进展, 2013 - cqvip.com
成人中枢神经系统存在着一定量的神经干细胞, 其具有两大关键能力; 自我更新和多向分化潜能.
缺血性脑卒中是一种由于由脑血流的缺失或减少引起的脑动脉闭塞, 进而导致脑组织梗死的脑 …